BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25049173)

  • 1. Propentophylline increases striatal dopamine release but dampens methamphetamine-induced dopamine dynamics: A microdialysis study.
    Gough B; Pereira FC; Fontes Ribeiro CA; Ali SF; Binienda ZK
    Neurochem Int; 2014 Oct; 76():109-13. PubMed ID: 25049173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats.
    Pereira FC; Lourenço E; Milhazes N; Morgadinho T; Ribeiro CF; Ali SF; Macedo TR
    Ann N Y Acad Sci; 2006 Aug; 1074():160-73. PubMed ID: 17105914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW; Bailey SL
    Ann N Y Acad Sci; 2000 Sep; 914():127-36. PubMed ID: 11085315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
    Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine modulates methamphetamine-induced dopamine dynamics in the rat caudate nucleus.
    Pereira FC; Gough B; Macedo TR; Ribeiro CF; Ali SF; Binienda ZK
    Neurotox Res; 2011 Jan; 19(1):94-101. PubMed ID: 20033362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats.
    Bowyer JF; Gough B; Slikker W; Lipe GW; Newport GD; Holson RR
    Pharmacol Biochem Behav; 1993 Jan; 44(1):87-98. PubMed ID: 8094252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Stephans SE; Yamamoto BK
    Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
    Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR
    J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine-stimulated striatal dopamine release declines rapidly over time following microdialysis probe insertion.
    Holson RR; Bowyer JF; Clausing P; Gough B
    Brain Res; 1996 Nov; 739(1-2):301-7. PubMed ID: 8955951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
    Wagstaff JD; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents.
    Ali SF; Newport GD; Slikker W
    Ann N Y Acad Sci; 1996 Oct; 801():187-98. PubMed ID: 8959033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW
    J Neurosci; 1999 Sep; 19(17):7653-60. PubMed ID: 10460271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
    Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
    Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
    Cass WA; Walker DJ; Manning MW
    Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of inorganic mercury (HgCl(2)) on striatal dopaminergic system.
    Faro LR; do Nascimento JL; Alfonso M; Durán R
    Ecotoxicol Environ Saf; 2001 Mar; 48(3):263-7. PubMed ID: 11222035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
    Abekawa T
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
    Hashitani T; Mizukawa K; Kumazaki M; Nishino H
    Neurosci Res; 1998 Jan; 30(1):43-52. PubMed ID: 9572579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.
    Meyer AC; Neugebauer NM; Zheng G; Crooks PA; Dwoskin LP; Bardo MT
    J Neurochem; 2013 Oct; 127(2):187-98. PubMed ID: 23875705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
    Cass WA
    J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.